130 combined drugs to convert to non-NHI reimbursement scheme.

Published: 2006-10-10 06:58:00

Updated: 2006-10-10 06:58:00

It is in dispute for the combined non-prescription drugs to transfer into the non-NHI reimbursement scheme. The Korea Medical Association (KMA) raised the question about the government's plan to reschedule the total 286 combined drugs into a non-NHI reimbursement scheme, including pseudoephedrine...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK